JP6147756B2 - 生体組織におけるメラニンなどの内因性蛍光体の特異的３ｄ検出、視覚化、および／または定量化のための非侵襲的方法 - Google Patents
生体組織におけるメラニンなどの内因性蛍光体の特異的３ｄ検出、視覚化、および／または定量化のための非侵襲的方法 Download PDFInfo
- Publication number
- JP6147756B2 JP6147756B2 JP2014540609A JP2014540609A JP6147756B2 JP 6147756 B2 JP6147756 B2 JP 6147756B2 JP 2014540609 A JP2014540609 A JP 2014540609A JP 2014540609 A JP2014540609 A JP 2014540609A JP 6147756 B2 JP6147756 B2 JP 6147756B2
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- melanin
- information
- pigmentation
- dimensional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 title claims description 162
- 238000000034 method Methods 0.000 title claims description 66
- 238000012800 visualization Methods 0.000 title claims description 8
- 238000011002 quantification Methods 0.000 title description 6
- 238000001514 detection method Methods 0.000 title 1
- 238000011282 treatment Methods 0.000 claims description 34
- 230000019612 pigmentation Effects 0.000 claims description 17
- 239000002537 cosmetic Substances 0.000 claims description 12
- 230000005284 excitation Effects 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 238000012417 linear regression Methods 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 9
- 230000035614 depigmentation Effects 0.000 claims description 8
- 238000001727 in vivo Methods 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 4
- 230000010354 integration Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 230000005855 radiation Effects 0.000 claims description 4
- 230000028709 inflammatory response Effects 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 38
- 210000003491 skin Anatomy 0.000 description 37
- 239000000047 product Substances 0.000 description 22
- 208000012641 Pigmentation disease Diseases 0.000 description 19
- 230000002123 temporal effect Effects 0.000 description 15
- 102000011782 Keratins Human genes 0.000 description 13
- 108010076876 Keratins Proteins 0.000 description 13
- 238000003384 imaging method Methods 0.000 description 8
- 239000013543 active substance Substances 0.000 description 6
- 238000012512 characterization method Methods 0.000 description 6
- 238000000386 microscopy Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000902 placebo Substances 0.000 description 3
- 229940068196 placebo Drugs 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000001161 time-correlated single photon counting Methods 0.000 description 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 230000009022 nonlinear effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 231100000435 percutaneous penetration Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 208000031019 skin pigmentation disease Diseases 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013334 tissue model Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/443—Evaluating skin constituents, e.g. elastin, melanin, water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6408—Fluorescence; Phosphorescence with measurement of decay time, time resolved fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
- G06T7/0014—Biomedical image inspection using an image reference approach
- G06T7/0016—Biomedical image inspection using an image reference approach involving temporal comparison
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/90—Determination of colour characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7242—Details of waveform analysis using integration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N2021/178—Methods for obtaining spatial resolution of the property being measured
- G01N2021/1785—Three dimensional
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10024—Color image
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10056—Microscopic image
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/10—Image acquisition modality
- G06T2207/10064—Fluorescence image
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30088—Skin; Dermal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Theoretical Computer Science (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Dermatology (AREA)
- Quality & Reliability (AREA)
- Radiology & Medical Imaging (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1160172A FR2982369B1 (fr) | 2011-11-08 | 2011-11-08 | Procede non invasif de detection, de visualisation et/ou de quantification 3d specifiques d'un fluorophore endogene tel la melanine au sein d'un tissu biologique. |
| FR1160172 | 2011-11-08 | ||
| PCT/IB2012/056230 WO2013068943A1 (fr) | 2011-11-08 | 2012-11-07 | Méthode non invasive de détection, visualisation et/ou quantification 3d spécifiques d'un fluorophore endogène comme la mélanine dans un tissu biologique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014532888A JP2014532888A (ja) | 2014-12-08 |
| JP6147756B2 true JP6147756B2 (ja) | 2017-06-14 |
Family
ID=47221509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540609A Active JP6147756B2 (ja) | 2011-11-08 | 2012-11-07 | 生体組織におけるメラニンなどの内因性蛍光体の特異的３ｄ検出、視覚化、および／または定量化のための非侵襲的方法 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP6147756B2 (fr) |
| KR (1) | KR102024956B1 (fr) |
| CN (1) | CN103930767B (fr) |
| FR (1) | FR2982369B1 (fr) |
| WO (1) | WO2013068943A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3024226B1 (fr) * | 2014-07-23 | 2019-05-10 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Procede et systeme de detection de givre |
| CN104297225B (zh) * | 2014-09-29 | 2018-02-16 | 无限极（中国）有限公司 | 一种细胞内黑色素的快速检测与成像的方法 |
| WO2016180095A1 (fr) * | 2015-05-08 | 2016-11-17 | 上海交通大学 | Procédé de détection in vivo, de manière non invasive, de lésions cutanées induites par la lumière ultraviolette, et dispositif de détection associé |
| JPWO2018008136A1 (ja) | 2016-07-07 | 2019-04-18 | オリンパス株式会社 | 画像処理装置および画像処理装置の作動方法 |
| US10732100B2 (en) * | 2018-06-29 | 2020-08-04 | L'oreal | Systems and methods for predicting sun protection factor of sunscreen formulations in vitro |
| US11333607B2 (en) | 2018-10-02 | 2022-05-17 | Electronics And Telecommunications Research Institute | Fluorescent signal detection apparatus using diagnostic kit |
| CN114246548B (zh) * | 2020-09-23 | 2024-05-24 | 中国中医科学院医学实验中心 | 一种用于痤疮炎症检测的装置、系统及其应用 |
| WO2024060018A1 (fr) * | 2022-09-20 | 2024-03-28 | Juan Liu | Méthode non invasive de détection, visualisation et/ou quantification d'un fluorophore endogène comme la mélanine dans un tissu biologique |
| FR3145861A1 (fr) | 2023-02-17 | 2024-08-23 | L’Oreal | Procédé non-invasif de détection, quantification et/ou localisation de certains types de mélanines et de leurs modifications structurelles sous l’action d’un stimulus et/ou d’un traitement au sein d’un tissu biologique ou tout autre échantillon contenant de la mélanine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5919710A (en) * | 1996-07-18 | 1999-07-06 | The United States Of America As Represented By The Secretary Of The Air Force | Optical method for quantitating dissolved oxygen in fuel |
| JP2003329588A (ja) * | 2002-05-14 | 2003-11-19 | Masaya Fukui | 材料識別方法および材料識別システム並びに材料識別装置 |
| US9750449B2 (en) * | 2003-12-12 | 2017-09-05 | Johnson & Johnson Consumer Inc. | Method of assessing skin |
| JP2005274308A (ja) * | 2004-03-24 | 2005-10-06 | Shiseido Co Ltd | 長波長紫外線誘導メラニン化抑制剤のスクリーニング方法および長波長紫外線誘導メラニン化抑制効果の評価方法 |
| JP5147379B2 (ja) * | 2007-12-18 | 2013-02-20 | 花王株式会社 | メラニン分布可視化方法及びその装置 |
| FR2944425A1 (fr) * | 2009-04-20 | 2010-10-22 | Oreal | Procede pour evaluer l'action d'un stimulus et/ou d'un traitement cense agir sur la distribution de la melanine dans des matieres keratiniques. |
-
2011
- 2011-11-08 FR FR1160172A patent/FR2982369B1/fr active Active
-
2012
- 2012-11-07 WO PCT/IB2012/056230 patent/WO2013068943A1/fr active Application Filing
- 2012-11-07 KR KR1020147012324A patent/KR102024956B1/ko active IP Right Grant
- 2012-11-07 CN CN201280054957.3A patent/CN103930767B/zh active Active
- 2012-11-07 JP JP2014540609A patent/JP6147756B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014532888A (ja) | 2014-12-08 |
| CN103930767A (zh) | 2014-07-16 |
| WO2013068943A1 (fr) | 2013-05-16 |
| KR20140090184A (ko) | 2014-07-16 |
| CN103930767B (zh) | 2017-09-05 |
| KR102024956B1 (ko) | 2019-09-24 |
| FR2982369A1 (fr) | 2013-05-10 |
| FR2982369B1 (fr) | 2016-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6147756B2 (ja) | 生体組織におけるメラニンなどの内因性蛍光体の特異的３ｄ検出、視覚化、および／または定量化のための非侵襲的方法 | |
| Paoli et al. | Multiphoton laser scanning microscopy on non-melanoma skin cancer: morphologic features for future non-invasive diagnostics | |
| Zhu et al. | Recent progress in tissue optical clearing | |
| Saager et al. | In vivo measurements of cutaneous melanin across spatial scales: using multiphoton microscopy and spatial frequency domain spectroscopy | |
| Roberts et al. | Non-invasive imaging of skin physiology and percutaneous penetration using fluorescence spectral and lifetime imaging with multiphoton and confocal microscopy | |
| Pena et al. | Imaging and quantifying drug delivery in skin–Part 2: Fluorescence andvibrational spectroscopic imaging methods | |
| König | Clinical in vivo multiphoton FLIM tomography | |
| Dancik et al. | Use of multiphoton tomography and fluorescence lifetime imaging to investigate skin pigmentation in vivo | |
| Ait El Madani et al. | In vivo multiphoton imaging of human skin: assessment of topical corticosteroid-induced epidermis atrophy and depigmentation | |
| Tsai et al. | Multiphoton microscopy in dermatological imaging | |
| Ashtikar et al. | Non-invasive depth profile imaging of the stratum corneum using confocal Raman microscopy: first insights into the method | |
| Benati et al. | Quantitative evaluation of healthy epidermis by means of multiphoton microscopy and fluorescence lifetime imaging microscopy | |
| Liang et al. | In vivo multiphoton microscopy for investigating biomechanical properties of human skin | |
| Cicchi et al. | Multimodal nonlinear microscopy: A powerful label-free method for supporting standard diagnostics on biological tissues | |
| JP5706226B2 (ja) | 皮膚内部のコラーゲン状態の評価方法及び皮膚老化の評価方法 | |
| Baldeweck et al. | In vivo multiphoton microscopy associated to 3D image processing for human skin characterization | |
| US20150157254A1 (en) | Method for diagnosing skin disease based on in vivo skin imaging | |
| Pena et al. | Multiphoton FLIM in cosmetic clinical research | |
| Schindele et al. | Multiphoton Tomography for in Vivo Skin Age Determination: Dermal autofluorescence and second harmonic generation allow non‐invasive imaging of biological tissue | |
| Wilson et al. | In vivo pump-probe microscopy of melanoma and pigmented lesions | |
| WO2024060018A1 (fr) | Méthode non invasive de détection, visualisation et/ou quantification d'un fluorophore endogène comme la mélanine dans un tissu biologique | |
| Pena et al. | Multiphoton imaging in cosmetics research | |
| Breunig et al. | Spectral characteristics of two-photon autofluorescence and second harmonic generation from human skin in vivo | |
| König et al. | In vivo two-photon imaging of topically applied care cosmetics and pharmaceuticals in human skin | |
| Wang et al. | Monitoring skin trauma healing in mice using second-harmonic generation combined with optical coherence tomography |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150812 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160420 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160516 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160805 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161111 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170417 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170517 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6147756 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |